Current Advances in Immunotherapy for Acute Leukemia: An Overview of Antibody, Chimeric Antigen Receptor, Immune Checkpoint, and Natural Killer | |
Shang, Yufeng; Zhou, Fuling | |
刊名 | FRONTIERS IN ONCOLOGY |
2019 | |
卷号 | 9 |
关键词 | immunotherapy acute myeloid leukemia acute lymphoblastic leukemia antibody-drug conjugate bispecific antibody chimeric antigen receptor immune checkpoint |
ISSN号 | 2234-943X |
DOI | 10.3389/fonc.2019.00917 |
URL标识 | 查看原文 |
收录类别 | SCIE |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4263081 |
专题 | 武汉大学 |
推荐引用方式 GB/T 7714 | Shang, Yufeng,Zhou, Fuling. Current Advances in Immunotherapy for Acute Leukemia: An Overview of Antibody, Chimeric Antigen Receptor, Immune Checkpoint, and Natural Killer[J]. FRONTIERS IN ONCOLOGY,2019,9. |
APA | Shang, Yufeng,&Zhou, Fuling.(2019).Current Advances in Immunotherapy for Acute Leukemia: An Overview of Antibody, Chimeric Antigen Receptor, Immune Checkpoint, and Natural Killer.FRONTIERS IN ONCOLOGY,9. |
MLA | Shang, Yufeng,et al."Current Advances in Immunotherapy for Acute Leukemia: An Overview of Antibody, Chimeric Antigen Receptor, Immune Checkpoint, and Natural Killer".FRONTIERS IN ONCOLOGY 9(2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论